Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection into epicardial fat pad to prevent post-CABG atrial fibrillation
IRCT20120215009014N338Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in Atrial fibrillation (AFib) comparing Botulinum toxin with Placebo (2 arms). Primary endpoint: Incidence of in-hospital atrial fibrillation after CABG. Started Feb 2020; status: completed.
02
Drugs
neuronox
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20120215009014N338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N338.